id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0523-0002,FDA,FDA-2013-N-0523,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs,Notice,30 Day Proposed Information Collection,2013-09-06T04:00:00Z,2013,9,2013-09-06T04:00:00Z,2013-10-08T03:59:59Z,2017-04-05T14:03:35Z,2013-21681,0,0,09000064813e0829
FDA-2013-N-0523-0001,FDA,FDA-2013-N-0523,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports; etc.",Notice,60 Day Proposed Information Collection,2013-05-10T04:00:00Z,2013,5,2013-05-09T04:00:00Z,2013-07-10T03:59:59Z,2017-04-05T14:02:55Z,2013-11127,0,0,09000064812d8133